Artificial Intelligence
Drug Discovery Services Market to reach a valuation of US$ 50.9 Bn by 2032 – Comprehensive Research Report by FMI
DUBAI, United Arab Emirates, Feb. 07, 2022 (GLOBE NEWSWIRE) — As per a recent report published by Future Market Insights, the global demand for drug discovery services is expected to rise at a 14.5% CAGR to acquire a valuation of US$ 50.9 Bn by the end of forecast period 2022-232. The global drug discovery services market size was valued at US$ 15.5 Bn in 2021 and is projected to reach a valuation of US$ 32 Bn by 2026
| Attributes | Details | |
| Drug Discovery Services Market CAGR (2022 – 2032) | 14.5% | |
| Drug Discovery Services Market (2026) | US$ 32 Bn | |
| Drug Discovery Services Market Attraction | Less stringent regulations make Asia Pacific key market | |
The global drug research services industry is booming as a result of increased funding for research and innovation in a multitude of segments. The drug discovery process is a significant part of the pharmaceutical sector.
The study on drug discovery services market finds that the efforts of researchers towards the development of new drug prototypes have popularized outsourcing of drug discovery services. Moreover, growing spending on research and the development of novel medications for the treatment of deadly diseases and disorders has stimulated the demand for drug discovery platform.
Request for Report Sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-14258
Pharmaceutical and biopharmaceutical businesses are opting for seamlessly engaged and multifunctional solution providers for drug discovery research, from the developing phase to the late testing stages. Emerging trends in drug discovery services market portends that pharmaceutical companies opt for outsourcing as a key choice to offset the shortage of in-house manpower required for new product development, as pharmaceutical businesses face great pressure to reduce overhead costs.
Restrictive laws regulating drug research and animal testing are projected to limit drug distribution to some extent. Drug discovery service organizations are facing restrictions due to a limitation of trained employees.
The use of animals in pharmaceutical research is governed by strict laws. Mice, rats, fish, amphibians, and reptiles are the most common animals utilized in scientific studies. Considerations over the ethical use of animal experimentation have prompted countries to enact animal safety and use statutes, which raises a number of impediments to the future of drug discovery services market.
The drug discovery trends indicate that Biologics, such as proteins, peptides, and monoclonal antibodies, account for more than half of the therapeutic possibilities in the initial cycle. In 2022, biologics are estimated to make up for approximately half of the income earned by the top 100 pharmaceutical drugs. As per the global market study on drug discovery services, they provide the drug discovery services market with highest growth potential through the forecast period.
Despite the fact that small-molecule pharmaceutical companies monopolize the global pharmaceutical market, players working with biologics, biosimilars, and large-molecule drugs are tapping into the drug discovery services market opportunities primarily to introduce new biologic-based treatments and rising revenue from current biologics.
All-in-all, the drug discovery services market is expected to reach a valuation of US$ 32 Bn by 2026.
Key Takeaways
- The drug discovery services market is divided into two types–chemistry and biology services. In 2020, the chemistry drug discovery services category held the greatest proportion of the market.
- Small molecules are expected to occupy the largest share of revenue when compared to biologics. Drug discovery statistics specify that small molecules are expected to generate more than US$ 10,800 million in revenue by the end of 2026.
- The oncology category is predicted to have the leading position, owing to the increasing number of cancer patients around the world.
- In comparison to other innovative drug discovery services, Hit-To-Lead identification is expected to acquire the most traction.
- As the most revenue generating phase, several CROs are already delivering Hit-to-lead identification services to pharmaceutical corporations.
Speak to our Research Expert: https://www.futuremarketinsights.com/ask-question/rep-gb-14258
“The Asia Pacific drug discovery services market growth is anticipated to be the highest during the projected duration, owing to expansions happening in the pharmaceutical and biopharmaceutical industry. A high proportion of contract research organizations (CROs), government incentives, high research and development in pharmaceutical industry, and the involvement of less restrictive standards for drug discovery programs (particularly in terms of using animals for research) across several APAC countries are some drivers sustaining the healthy growth of the drug discovery services market.”, opines a seasoned FMI analyst.
Comparative View of Adjacent Drug Discovery Services Market
| Attributes | Drug Discovery Services Market |
Computer-aided Drug Discovery Market |
Artificial Intelligence in Drug Discovery Market |
| CAGR
(2022-2032) |
14.5% | 15% | 40% |
| Market Value
(2026) |
US$ 32 Bn | US$ 7.9 Bn | US$ 5 Bn |
| Growth Factor | Readiness to outsource drug discovery services to support market growth. | Cost-efficiency of drug development process to underpin adoption. | Growing adoption of innovative drug development processes to reduce market times. |
| Opportunity | Emerging Asia Pacific market hold high attraction quotient. | Availability of high-end software and progressive improvement in their efficiency. | Increased demand for drugs to curb the COVID-19 pandemic. |
| Key Trends | Cross-industry collaboration to improve drug efficiency and boost adoption. | Strategic tie-ups for product innovation is a go-to market move. | Time is money. Manufacturers resort to rapid drug development. |
Ask For Country-Specific Data@ https://www.futuremarketinsights.com/ask-country-specific/rep-gb-14258
Competitive Landscape
The COVID-19 pandemic highlighted the importance of outsourcing drug discovery services for companies and research groups in North America. These companies are now working together with the government to facilitate the drug discovery process.
- Existencia, a business using artificial intelligence in drug discovery, announced a collaboration with Diamond Light Source and Scripps Research on March 31, 2020, to identify COVID-19 antiviral treatments.
- Samsung Biologics, a South Korean pharmaceutical business, has signed a long-term partnership with Eli Lilly and Company to develop bamlanivimab, an investigational COVID-19 virus-neutralizing antibody.
Genesis Therapeutics and Genentech announced a multi-target drug discovery AI partnership in November 2020. Genesis’ graph machine learning and drug discovery skills will be used in this cooperation to identify novel drug candidates for therapeutic targets in a variety of illness domains.
Explore FMI’s Extensive ongoing Coverage on Healthcare Domain
Peritoneal Catheter Systems Market: According to the latest research by FMI, Peritoneal Catheter Systems is set to witness a 7.1% growth during the year 2021-2031.
Patient Hygiene Aids Market: According to the latest research by Future Market Insights, Patient Hygiene Aids Market is set to experience 6.5% growth during the year 2021-2031.
Paediatric & Neonatal Testing Kits Market: According to the latest research by Future Market Insights, the Paediatric & Neonatal Testing Kits Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031.
Wound Skin Care Market: According to the latest research by Future Market Insights, Wound Skin Care market is set to witness a 6.2% growth during the year 2021-2031.
Venous device market: According to the latest research by Future Market Insights, Venous device market is set to experience 6.5% growth during the year 2021-2031.
Birth Tissue Products Market: According to the latest research by Future Market Insights, the birth tissue products market is ready to take its global graph on the upward direction to reach its high point.
Transplant Monitoring Kits Market: According to the latest research by Future Market Insights, Transplant Monitoring Kits Market is expected to witness robust growth with 4-5% CAGR during the forecast period from 2021 to 2031.
Topical Bioadhesives Market: According to the latest research by Future Market Insights, Topical Bioadhesives Market is set to experience growth during the year 2021-2031.
Stress Tracking Devices Market: According to the latest research by Future Market Insights, stress tracking devices market is set to experience positive growth during the year 2021-2031.
Vascular Boot market: According to the latest research by Fact.MR, Vascular boot market is set to witness a 5.5% growth during the year 2021-2031.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: [email protected]
For Media Enquiries: [email protected]
Website: https://www.futuremarketinsights.com/
Report: https://www.futuremarketinsights.com/reports/drug-discovery-services-market
Press Release Source: https://www.futuremarketinsights.com/press-release/drug-discovery-services-market
Artificial Intelligence
Doosan Robotics Unveils Max-Powered ‘PRIME-SERIES’ of Collaborative Robots at Automate 2024
The New P-SERIES Unleashes Efficiency with a 30 Kilogram Payloadand the Longest Reach of Any Cobot to Date
CHICAGO, May 6, 2024 /PRNewswire/ — Doosan Robotics Inc., one of the world’s leading collaborative robot (cobot) manufacturers, unveiled its newest and most powerful P-SERIES (PRIME-SERIES) today at Automate 2024, bringing to the world of robotics the longest reaching cobot to date.
Today’s P-SERIES announcement by Doosan Robotics was marked by a show floor unveiling of the new P3020 – the world’s most powerful cobot for palletizing in existence. The P3020 offers a payload of 30kg (60lbs) and reach of 2,030mm (80in), bringing the ability to palletize from floor to 2m high (stacking up to 10 layers of boxes approximately 8 inches tall) using its simple fixed base without a lift.
Doosan Robotics has successfully dominated the high-payload cobot market in the 20kg range and above, which includes advanced palletizing solutions. Since launching the H-SERIES in 2022, Doosan Robotics has attracted major global customers such as Schiphol Airport and Wacker Korea, significantly enhancing its global market share by 72%. This year, with the introduction of the P-SERIES, the cobot featuring the highest payload and reach yet, expectations are set to soar beyond previous achievements.
Additional key features of the P-SERIES cobot lineup include lower power consumption compared to similar payload cobots by applying its built-in gravity compensation mechanism, inherent wrist-singularity free, and a 5 degree-of-freedom movement with the 4th axis removed and 6th axis speed increased to 360 degrees/second. Doosan Robotics’ continued priority on optimal safety across its solutions is also fully present in the new P3020. This includes achieving the highest PL (e) and Cat 4 safety ratings to ensure both a max-powered and max-safety experience for users.
The motion platform company’s newly unveiled P3020 palletization cobot will be on full display (Booth #850) at Automate 2024 (May 6-9), alongside the company’s ready-to-sell solutions with best-in class partners in Machine Tending, Palletizing, Welding, and Food & Beverage services.
Driven by its vision to elevate everyday experiences and redefine labor workflows, Doosan Robotics provides a wide, exceptional range of AI cobots aimed to bring about a paradigm shift across various sectors, such as palletizing, manufacturing, logistics, food & beverage, architecture, and service industries. These cutting-edge solutions transcend the constraints of conventional robotics, adeptly maneuvering through intricate scenarios while infusing tasks with enhanced efficiency, safety, and ingenuity. Moreover, the AI system boasts continuous learning capabilities, effortlessly updating its model by autonomously downloading required modules for smooth integration.
“As a motion platform company, Doosan Robotics is meeting the ever-growing need for cobots to mimic human motion, powerfully and safely,” said William Ryu, CEO at Doosan Robotics. “The robotics industry continues to grow at an exponential pace and our lineup of software, cobots and AI differentiates us in our mission to develop cobots with a ‘max-powered, max-efficiency, max-safety’ mindset.”
For more details and videos on the new P3020 cobot by Doosan Robotics, please visit the Doosan Robotics YouTube channel here. For more info, images, and other assets regarding Doosan Robotics’ Automate 2024 overall presence, please visit the press kit here or contact [email protected].
ABOUT DOOSAN ROBOTICSDoosan Robotics is a global leader in collaborative robot solutions, embodying the principle of ‘Innovation in every motion, revolutionizing the way we work.’ Doosan robots, known for world-class safety and precision, enhance task efficiency across various sectors from manufacturing to service, enabling people to focus on more valuable work. More information about Doosan Robotics is available at https://www.doosanrobotics.com/en/.
Photo – https://mma.prnewswire.com/media/2405465/Doosan_Robotics_Unveils_Max_Powered_PRIME_SERIES.jpg
Logo – https://mma.prnewswire.com/media/2403399/Doosan_Robotics_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/doosan-robotics-unveils-max-powered-prime-series-of-collaborative-robots-at-automate-2024-302136958.html
Artificial Intelligence
Enghouse announces expansion of our cloud contact center technology in the Middle East through our partnership with Voxtron
MARKHAM, ON, May 6, 2024 /PRNewswire/ — Enghouse Interactive, a global leader in contact center and video technology solutions, is proud to announce a strategic partnership with Voxtron, the premier provider of call center solutions in the Middle East. This collaboration is marked by Voxtron’s introduction of the innovative Voxvantage Cloud Contact Center as a Service (CCaaS), leveraging advanced contact center technology from Enghouse.
The Official Launch will take place at the Grand Hyatt Dubai. Industry participants and media are invited to RSVP to attend by emailing [email protected].
Date: 9th May 2024 Time: 6:00 PM to 10:00 PM Venue: Grand Hyatt Dubai, RSVP: [email protected]
Voxvantage CCaaS marks a significant advancement for Enghouse Systems, underscoring a commitment to enhancing customer experiences throughout the region. Hosted on the robust data center infrastructure of Moro Hub, Voxtron guarantees exceptional reliability, security, and scalability.
The launch will feature distinguished speakers, including Tracy Reynolds, Canadian Consul General in Dubai, Vincent Mifsud, Global President of Enghouse Systems, and Arif AlMalik, Chief Digital Products Officer of Moro Hub. They will explore the transformative potential of contact solutions in improving customer experience (CX) in the Middle East.
Mr. Mifsud expressed his enthusiasm about the partnership, stating, “We are excited to collaborate with Voxtron and Moro Hub. This partnership is crucial as we aim to provide our call center technology, enhance our presence across the Middle East by providing customers with leading technology that improves customer experiences.”
The event will also offer excellent networking opportunities and insightful discussions on the future of customer engagement solutions.
About Enghouse Interactive:
Enghouse Interactive, a subsidiary of Enghouse Systems Limited, is a global leader in contact center software and video technology solutions offering its customers and partners the valuable advantage of choice. Enghouse Interactive empowers businesses to transform contact centers from cost centers into powerful growth engines by simplifying complex integrations through open standards and supporting various telephony technologies to ensure seamless customer accessibility across channels and locations.
About Voxtron:
Voxtron Middle East is headquartered in Dubai, U.A.E., and has a global presence with offices and affiliates in Qatar, India, Germany, Austria, Belgium, Italy, Turkey, Tunisia, Hong Kong, Portugal, and Thailand. Voxtron has been delivering cost-effective customer engagement optimization solutions in collaboration with leading technology vendors such as Enghouse Interactive, SAGE, Verint, and Clarabridge, for over a decade. This extensive portfolio positions Voxtron as a unique provider capable of delivering complete, fully-featured solutions to customers and partners.
Enghouse Video Contact: Tim Peters, VP, Global Demand Generation Leader, Enghouse Systems, [email protected]
View original content:https://www.prnewswire.co.uk/news-releases/enghouse-announces-expansion-of-our-cloud-contact-center-technology-in-the-middle-east-through-our-partnership-with-voxtron-302136981.html
Artificial Intelligence
Appdome Named “Editor’s Choice for Mobile App Security” in Coveted Global InfoSec Awards during RSA Conference 2024
Appdome Wins in 12th Annual Global InfoSec Awards at #RSAC 2024
SAN FRANCISCO, May 6, 2024 /PRNewswire/ — Appdome, the mobile app economy’s one-stop shop for mobile app defense, is proud to announce it has won Editor’s Choice for Mobile App Security from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine.
The Appdome platform is the first and only full lifecycle mobile app defense platform to automatically build, monitor and respond with any or all of 300+ mobile app defenses including security, anti-fraud, anti-malware, anti-cheat, anti-bot, geo compliance and social engineering for any mobile app in minutes with no SDK or coding required – all within the CI/CD pipeline. As a mobile app security engine for DevOps, Appdome enables mobile app developers, even those lacking security expertise, with an easy and fast way to secure all Android & iOS apps without any additional work. By automating security in the mobile pipeline, Appdome eliminates the cost and complexity of manually coding security, fraud and compliance features so mobile brands can confidently ship secure mobile apps faster with always-on protections to meet their critical mobile business needs.
“We’re proud to be recognized as Editor’s Choice for Mobile App Security by Cyber Defense Magazine in its 12th year of awarding the most prestigious and coveted cybersecurity award in the world,” said Tom Tovar, co-creator and CEO of Appdome. “With organizations battling unnecessary complexity from point products, the Appdome platform approach to mobile defense is leading the way to unify 300+ protections across security, anti-fraud, bot defense, mobile EDR, and compliance for all internal (employee) and external (consumer) facing mobile applications under a single pane of glass.”
“We scoured the globe looking for cybersecurity innovators that could make a huge difference and potentially help turn the tide against the exponential growth in cyber-crime. Appdome is absolutely worthy of Editor’s Choice for Mobile App Security coveted award and consideration for deployment in your environment,” said Yan Ross, Global Editor of Cyber Defense Magazine.
Appdome and all award winners located here: http://www.cyberdefenseawards.com/
Appdome continues to deliver waves of innovation in 2024 including:
Appdome Unveils World’s first Agentless Mobile EDR & MTDAppdome MOBILEBot ProtectionAppdome World’s First Real-Time Defense for Social EngineeringAppdome Revolutionizes Geo Defense for Mobile BrandsPlease join Appdome at the RSA Conference 2024 booth #2339 to see the award winning Appdome Platform in action!
Learn more at www.appdome.com.
About AppdomeThe Appdome mission is to protect every mobile app in the world and the people who use mobile apps in their lives and at work. Appdome provides the mobile industry’s only Unified Mobile App Defense platform, powered by a patented mobile coding engine, Threat-Events™ Threat-Aware UX/UI Control and ThreatScope™ Mobile XDR. Using Appdome, mobile brands eliminate complexity, ship faster and save money by delivering 300+ Certified Secure™ mobile app security, anti-malware, anti-fraud, mobile anti-bot, anti-cheat, geo compliance, MiTM attack prevention, code obfuscation, social engineering and other protections in Android and iOS apps with ease, inside the mobile DevOps and CI/CD pipeline. Leading financial, healthcare, government and m-commerce brands use Appdome to protect Android and iOS apps, mobile customers and mobile businesses globally. Appdome holds several patents including U.S. Patents 9,934,017 B2, 10,310,870 B2, 10,606,582 B2, 11,243,748 B2 and 11,294,663 B2. Additional patents pending.
About Cyber Defense MagazineCyber Defense Magazine is the premier source of cyber security news and information for InfoSec professions in business and government. We are managed and published by and for ethical, honest, passionate information security professionals. Our mission is to share cutting-edge knowledge, real-world stories and awards on the best ideas, products, and services in the information technology industry. We deliver electronic magazines every month online for free, and special editions exclusively for the RSA Conferences. CDM is a proud member of the Cyber Defense Media Group. Learn more about us at https://www.cyberdefensemagazine.com and visit https://www.cyberdefensetv.com and https://www.cyberdefenseradio.com to see and hear some of the most informative interviews of many of these winning company executives. Join a webinar at https://www.cyberdefensewebinars.com and realize that infosec knowledge is power.
Logo – https://mma.prnewswire.com/media/772169/4688418/AppDome_Logo_9_27_23.jpg
View original content:https://www.prnewswire.co.uk/news-releases/appdome-named-editors-choice-for-mobile-app-security-in-coveted-global-infosec-awards-during-rsa-conference-2024-302136929.html
-
Artificial Intelligence3 days agoCleverTap launches Clever.AI, the AI-Driven Edge for Customer Engagement & Retention
-
Artificial Intelligence7 days agoSUNRATE partners with YeePay to empower Chinese companies to navigate global expansion
-
Uncategorized7 days agoIntel unveils AI-Platform Innovation for Paris 2024
-
Uncategorized4 days ago
Improving the Developer Journey in Crafting Artificial Intelligence Applications
-
Artificial Intelligence5 days agoAppdome Unveils World’s First Agentless Mobile EDR & MTD
-
Uncategorized4 days ago
Unveiling the Complex Psychological Implications of Artificial Intelligence
-
Artificial Intelligence4 days agoBitrue expands Bitcoin Runes Offerings with GPTV Listing and Staking Options
-
Artificial Intelligence4 days ago5G Enterprise Market Projected to Reach $115.81 billion by 2030 – Exclusive Report by 360iResearch
